tiprankstipranks
Contineum Therapeutics, Inc. Class A (CTNM)
NASDAQ:CTNM
US Market
Want to see CTNM full AI Analyst Report?

Compare Contineum Therapeutics, Inc. Class A (CTNM) vs. Competitors

214 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Contineum Therapeutics, Inc. Class A
$13.53
$496.86M
-5.28
232.49%
5 Buy
1 Hold
0 Sell
Strong Buy
Tvardi Therapeutics
$3.39
$29.55M
-1.38
-87.66%
4 Buy
2 Hold
1 Sell
Moderate Buy
Capricor Therapeutics
$34.70
$1.94B
-12.77
142.62%
8 Buy
0 Hold
0 Sell
Strong Buy
Alpha Tau Medical Ltd
$8.03
$734.00M
-9.36
225.95%
2 Buy
1 Hold
0 Sell
Moderate Buy
Immuneering
$5.56
$338.78M
-5.17
316.28%
5 Buy
0 Hold
0 Sell
Strong Buy
enGene Holdings
$8.07
$487.01M
-5.39
93.85%
6 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CTNM
Contineum Therapeutics, Inc. Class A
13.20
9.23
232.49%
TVRD
Tvardi Therapeutics
3.14
-24.65
-88.70%
CAPR
Capricor Therapeutics
30.91
20.61
200.10%
DRTS
Alpha Tau Medical Ltd
8.54
5.94
228.46%
IMRX
Immuneering
5.37
4.12
329.60%
ENGN
enGene Holdings
7.25
3.57
97.01%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts